Literature DB >> 19520739

Stimulation of incretin secretion by dietary lipid: is it dose dependent?

Stephanie M Yoder1, Qing Yang, Tammy L Kindel, Patrick Tso.   

Abstract

After the ingestion of nutrients, secretion of the incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) by the enteroendocrine cells increases rapidly. Previous studies have shown that oral ingestion of fat stimulates secretion of both incretins; however, it is unclear whether there is a dose-dependent relationship between the amount of lipid ingested and the secretion of the hormones in vivo. Recently, we found a higher concentration of the incretin hormones in intestinal lymph than in peripheral or portal plasma. We therefore used the lymph fistula rat model to test for a dose-dependent relationship between the secretion of GIP and GLP-1 and dietary lipid. Under isoflurane anesthesia, the major mesenteric lymphatic duct of male Sprague-Dawley rats was cannulated. Each animal received a single, intraduodenal bolus of saline or varying amounts of the fat emulsion Liposyn II (0.275, 0.55, 1.1, 2.2, and 4.4 kcal). Lymph was continuously collected for 3 h and analyzed for triglyceride, GIP, and GLP-1 content. In response to increasing lipid calories, secretion of triglyceride, GIP, and GLP-1 into lymph increased dose dependently. Interestingly, the response to changes in intraluminal lipid content was greater in GLP-1- than in GIP-secreting cells. The different sensitivities of the two cell types to changes in intestinal lipid support the concept that separate mechanisms may underlie lipid-induced GIP and GLP-1 secretion. Furthermore, we speculate that the increased sensitivity of GLP-1 to intestinal lipid content reflects the hormone's role in the ileal brake reflex. As lipid reaches the distal portion of the gut, GLP-1 is secreted in a dose-dependent manner to reduce intestinal motility and enhance proximal fat absorption.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520739      PMCID: PMC2724086          DOI: 10.1152/ajpgi.90601.2008

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  36 in total

1.  Glucagon-like peptide-1: a potent regulator of food intake in humans.

Authors:  J P Gutzwiller; B Göke; J Drewe; P Hildebrand; S Ketterer; D Handschin; R Winterhalder; D Conen; C Beglinger
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

2.  Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.

Authors:  M A Nauck; U Niedereichholz; R Ettler; J J Holst; C Orskov; R Ritzel; W H Schmiegel
Journal:  Am J Physiol       Date:  1997-11

3.  Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.

Authors:  Michael J Theodorakis; Olga Carlson; Spyros Michopoulos; Máire E Doyle; Magdalena Juhaszova; Kalliopi Petraki; Josephine M Egan
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-10-11       Impact factor: 4.310

4.  Rapid synthesis and secretion of intestinal apolipoprotein A-IV after gastric fat loading in rats.

Authors:  M D Rodriguez; T J Kalogeris; X L Wang; R Wolf; P Tso
Journal:  Am J Physiol       Date:  1997-04

5.  Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.

Authors:  P J Larsen; C Fledelius; L B Knudsen; M Tang-Christensen
Journal:  Diabetes       Date:  2001-11       Impact factor: 9.461

6.  GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine.

Authors:  Kristine Mortensen; Louise Lundby Christensen; Jens Juul Holst; Cathrine Orskov
Journal:  Regul Pept       Date:  2003-07-15

7.  Stereospecific effects of fatty acids on proglucagon-derived peptide secretion in fetal rat intestinal cultures.

Authors:  A S Rocca; P L Brubaker
Journal:  Endocrinology       Date:  1995-12       Impact factor: 4.736

8.  Using the lymph fistula rat model to study the potentiation of GIP secretion by the ingestion of fat and glucose.

Authors:  Wendell J Lu; Qing Yang; William Sun; Stephen C Woods; David D'Alessio; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-03-27       Impact factor: 4.052

9.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

Authors:  M J Perley; D M Kipnis
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

10.  Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1.

Authors:  Hyeung-Jin Jang; Zaza Kokrashvili; Michael J Theodorakis; Olga D Carlson; Byung-Joon Kim; Jie Zhou; Hyeon Ho Kim; Xiangru Xu; Sic L Chan; Magdalena Juhaszova; Michel Bernier; Bedrich Mosinger; Robert F Margolskee; Josephine M Egan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-27       Impact factor: 11.205

View more
  35 in total

Review 1.  Diet: friend or foe of enteroendocrine cells--how it interacts with enteroendocrine cells.

Authors:  Sofia Moran-Ramos; Armando R Tovar; Nimbe Torres
Journal:  Adv Nutr       Date:  2012-01-05       Impact factor: 8.701

Review 2.  Role of gut nutrient sensing in stimulating appetite and conditioning food preferences.

Authors:  Anthony Sclafani; Karen Ackroff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-03-21       Impact factor: 3.619

Review 3.  Intestinal GLP-1 and satiation: from man to rodents and back.

Authors:  R E Steinert; C Beglinger; W Langhans
Journal:  Int J Obes (Lond)       Date:  2015-08-28       Impact factor: 5.095

4.  Differential responses of the incretin hormones GIP and GLP-1 to increasing doses of dietary carbohydrate but not dietary protein in lean rats.

Authors:  Stephanie M Yoder; Qing Yang; Tammy L Kindel; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-03       Impact factor: 4.052

5.  The role of apolipoprotein A-IV in regulating glucagon-like peptide-1 secretion.

Authors:  Fei Wang; Qing Yang; Sarah Huesman; Min Xu; Xiaoming Li; Danwen Lou; Stephen C Woods; Corina Marziano; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-20       Impact factor: 4.052

6.  GLP-1 released to the mesenteric lymph duct in mice: effects of glucose and fat.

Authors:  Lena Ohlsson; Alison B Kohan; Patrick Tso; Bo Ahrén
Journal:  Regul Pept       Date:  2014-02-28

Review 7.  Effects of GLP-1 on appetite and weight.

Authors:  Meera Shah; Adrian Vella
Journal:  Rev Endocr Metab Disord       Date:  2014-09       Impact factor: 6.514

8.  Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice.

Authors:  Matthew J Potthoff; Austin Potts; Tianteng He; João A G Duarte; Ronald Taussig; David J Mangelsdorf; Steven A Kliewer; Shawn C Burgess
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-20       Impact factor: 4.052

9.  Apolipoprotein A-IV enhances cholecystokinnin secretion.

Authors:  Jesse Zhan; Jonathan Weng; Brian G Hunt; W Sean Davidson; Min Liu; Chunmin C Lo
Journal:  Physiol Behav       Date:  2018-01-31

10.  Is apolipoprotein A-IV rate limiting in the intestinal transport and absorption of triglyceride?

Authors:  Alison B Kohan; Fei Wang; Xiaoming Li; Abbey E Vandersall; Sarah Huesman; Min Xu; Qing Yang; Danwen Lou; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-04-18       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.